StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Theriva Biologics's total debt was $63.00K at Dec 31, 2023. For fiscal 2023 it was $63.00K, up 10.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$63.00K+10.5%
FY2022Dec 31, 2022$57.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$63.00K+10.5%
Q3 FY2023Sep 30, 2023$65.00K+25.0%
Q2 FY2023Jun 30, 2023$67.00K+19.6%
Q1 FY2023Mar 31, 2023$66.00K-2.9%
Q4 FY2022Dec 31, 2022$57.00K–
Q3 FY2022Sep 30, 2022$52.00K–
Q2 FY2022Jun 30, 2022$56.00K–
Q1 FY2022Mar 31, 2022$68.00K–

More Theriva Biologics figures

See a number that looks wrong?